We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Gemcitabine-Cisplatin Combination a New Standard in Pancreatic Cancer with Germline BRCA or PALB2 Mutation.
- Authors
Kuznar, Wayne
- Abstract
In this article the author talks about platinum-based therapy represents a new standard of care in patients with pancreatic cancer and germline BRCA or PALB2 mutation, based on data reported at the 2020 Gastrointestinal Cancers Symposium. Topics discussed recommendation for moving forward, and believe these data define a reference regimen for germline BRCA-mutated, PALB2-mutated pancreas cancer, and the views of Eileen M. O'Reilly, Section Head, at Memorial Sloan Kettering Cancer Center, on it.
- Subjects
PANCREATIC cancer; GERM cells
- Publication
Oncology Practice Management, 2020, Vol 10, Issue 4, p20
- ISSN
2164-4403
- Publication type
Article